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Abstract
CHARGE syndrome is caused by mutations in the CHD7 gene. Several organ systems including the retina, cranial nerves,
inner ear and heart are affected in CHARGE syndrome. However, the mechanistic link between mutations in CHD7 and many
of the organ systems dysfunction remains elusive. Here, we show that Chd7 is required for the organization of the neural
retina in zebrafish. We observe an abnormal expression or a complete absence of molecular markers for the retinal ganglion
cells and photoreceptors, indicating that Chd7 regulates the differentiation of retinal cells and plays an essential role in
retinal cell development. In addition, zebrafish with reduced Chd7 display an abnormal organization and clustering of
cranial motor neurons. We also note a pronounced reduction in the facial branchiomotor neurons and the vagal motor
neurons display aberrant positioning. Further, these fish exhibit a severe loss of the facial nerves. Knock-down of Chd7
results in a curvature of the long body axis and these fish develop irregular shaped vertebrae and have a reduction in bone
mineralization. Chd7 knockdown also results in a loss of proper segment polarity illustrated by flawed efnb2a and ttna
expression, which is associated with later vascular segmentation defects. These critical roles for Chd7 in retinal and vertebral
development were previously unrecognized and our results provide new insights into the role of Chd7 during development
and in CHARGE syndrome pathogenesis.
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Introduction
Mutations in the CHD7 gene (NM_017780) in 8q12.1 were
identified as causative for CHARGE (Coloboma, Heart defects,
Atresia of the choanae, Retarded growth and development,
Genital hypoplasia, Ear anomalies; OMIM # 214800)) syndrome
[1,2,3,4,5]. Heterozygosity for nonsense, deletion or missense
CHD7 mutations is estimated to occur in 60–80% of patients with
CHARGE syndrome; these mutations are distributed throughout
the coding sequence and do not appear to be correlated with
specific aspects of the clinical phenotype [6,7,8]. The majority of
CHD7 mutations identified thus far are de novo; however, evidence
for germline mosaicism has been suggested for families with
multiple affected siblings [9] . Children affected by CHARGE
syndrome have a variable association of features including ocular
deficits, heart malfunctioning, olfactory dysfunction, retarded
growth, vestibular dysfunction, cranial nerve anomalies and
intellectual disability [2,4,10]. All of these characteristics have
variable degrees of penetrance, with some being present in
virtually all CHARGE patients, whereas others are less frequently
observed [11]. Although there is clear evidence that mutations in
CHD7 gene are causative in CHARGE syndrome, the pathogenic
mechanisms elicited by these mutations that lead to organs and
systems dysfunction are not fully understood.
Chd7 is one of nine members of the chromodomain helicase
DNA- binding (Chd) domain family of ATP-dependent chromatin
remodeling enzymes [12]. It consists of functional domains such as
a chromatin organization modifier, SNF2-related helicase/
ATPase and BRK [12,13]. Recently, DNA-binding sites on
chromatin have shown that chd7 binding is correlated to areas of
mono- and dimethylated lysine 4 of histone H3 [14,15]. The Chd7
Drosophila ortholog, Kismet down-regulates transcriptional elonga-
tion by RNA polymerase II through the recruitment of ASH1 and
TRX and may be involved in the maintenance of stem cell
pluripotency by regulating methylation of histone H3 lysine 27.
Chd7 is also implicated in cell fate specification of mesenchymal
stem cells [16] . During osteoblast and adipocyte differentiation,
Chd7 forms a complex with NLK, SETDB1 and PPAR-c, then
binds to histone H3 at PPAR-c target promoters and suppresses
ligand-induced transactivation of PPAR-c target genes, which
leads to a change in cell fate [16] . Recently, Chd7 has been shown
act synergistically with PBAF to promote neural crest gene
expression and cell migration [17]. Thus, Chd7 is thought to play
a variety of essential roles during development in many species.
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human diseases has been improved through the study of model
organisms. Zebrafish are a well-established model used to study
developmental biology because of their accessibility, optical
transparency and rapid development. Over the past decade, the
utility of this model organism in investigations of human health
and disease has become more explicit. Major advantages of this
vertebrate model include a high degree of homology to human
genes, as well as conservation of developmental pathways.
Zebrafish chd7 gene is located on chromosome 2 and alignment
of the zebrafish genomic sequence with mouse Chd7 and human
CHD7 shows the gene structure is conserved across species [18].
Given that the zebrafish chd7 gene is highly similar to the human
CHD7 gene, elucidating roles for Chd7 in zebrafish development
could significantly contribute to our understanding of the function
of Chd7 in CHARGE syndrome pathogenesis. Therefore, we
sought to utilize zebrafish to assess the pathogenic effect of the loss
of function of Chd7 and understand the role of the zebrafish
homolog of the mammalian Chd7 during development. We show
that chd7 is robustly expressed in developing zebrafish embryos,
particularly in the retina, hindbrain and tail bud. Loss of function
of Chd7 results in several defects including abnormal neural
development, curvature of the long axis of the body, abnormal
cranial neural crest (CNC) development, otolith anomalies, smaller
eye and pericardial edema. These defects are similar to the major
congenital anomalies associated with human CHD7 mutations in
CHARGE syndrome. Finally, we reveal for the first time a critical
role of Chd7 in retinal organization and bone mineralization.
Results
Chd7 transcript is broadly expressed in developing
zebrafish
To begin to explore the role of Chd7 in developing zebrafish, we
first analyzed the developmental expression of chd7 mRNA. In situ
hybridization results showed that chd7 was expressed relatively
ubiquitously throughout early zebrafish embryogenesis (Fig. 1 A–C)
until around the 13 somite stage of development when more discrete
expression in the eye primordium, and the perimeter of the somites was
observed (Fig. 1 D). As somitogenesis continued, chd7 became highly
expressed inthe retina aswell asinthe brain, somites,and tailbud of the
embryo (Fig. 1 E–F). Finally at 48 hpf, chd7 expression in the tail began
to diminish, however expression in the brain and in the eye remained
strong (Fig. 1 G). The sense probe did not show any in situ staining
suggesting that there was no non-specific hybridization (Fig. 1 E9).
Loss of function of Chd7 leads to several and widespread
morphological abnormalities
Next, we depleted zebrafish embryos of Chd7 protein using an
antisense morpholino oligonucleotide (MO) designed against the
translation initiation sites of chd7 mRNA. Embryos injected with
Figure 1. Chd7 expression patterns during zebrafish embryogenesis. Chd7 was expressed ubiquitously throughout the embryo during epiboly
(A), at the 4 somite stage (B), and at the 8 somite stage (C). (D) At the 13 somite stage, expression remained relatively ubiquitous, but with stronger
expression noted within theretinaandattheperimeters of developed somites.(E) Atthe18somite stage, tissue-specificexpression was observedin the
eyes, brain, somites, and tailbud. This expression pattern remained through 24 hours post fertilization (F). (E9) No staining occurred when hybridized
with a chd7 sense probe. (G) At 48 hours post fertilization, chd7 expression began to diminish from the body of the zebrafish but remained in the eye
and in the brain. e, eye; ep, eye primordium; mb, midbrain; hp, head primordium; s, somite; t, tail; tb, tailbud; y, yolk; ye, yolk extension.
doi:10.1371/journal.pone.0031650.g001
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axis of the body, a flattening of the head, abnormal tail fins,
smaller eyes and heart defects (n=12, A total of 498 fish used;
Fig. 2, 3 A–C). These defects were observed in a dosage-dependent
manner (Figure S1). As embryos were injected with increasing
concentrations of chd7-MO, the resulting defects became more
severe (Figure S1 C–D)
To exclude the possibility that this phenotype may have resulted
from non-specific or mistargeting effects of the MO, we also
designed and injected zebrafish embryos with a chd7 splice-
blocking morpholino (SBMO) and control 5-bp mismatch MO.
We recently showed by RT-PCR analysis that the morpholino-
targeted region exhibited abnormal splicing of chd7 in embryos
injected with chd7 SBMO and normal splicing in uninjected and
control-MO injected embryos [19]. Embryos injected with the
chd7 SBMO exhibited morphological defects similar to those
observed in the chd7-MO morphants (Fig, 2 D). On the other
hand, all control MO-injected larvae developed normally (n=12,
436 fish; Fig. 2 E and Fig. 3) and no apparent phenotype was
observed when compared to untreated wild-type embryos (n=12,
510 fish; Fig. 2 A). To further confirm that the lack of Chd7
underlies all the phenotypic alterations observed in chd7-MO
zebrafish, a rescue experiment was performed. We found that
expression of chd7 mRNA which had no complementary sequence
to chd7-MO can correct all the developmental defects (n=6, 249
fish; Fig. 2 E) and no apparent phenotype was observed when
compared to control-MO fish (Fig. 2). Thus, the amount of newly-
synthesized Chd7 coded by the rescuing mRNA in the initial
stages was sufficient to prevent the developmental anomalies
imparted by the chd7-MO. Altogether these findings were
consistent with a reduction in Chd7 expression and they suggest
that the phenotype observed with chd7-MO-injected embryos was
a specific and due to a direct result of Chd7 protein depletion.
We focused the analysis of the loss of function of Chd7 in
embryos injected with 2 ng/nl of chd7-MO. At 48 hpf, we found
that chd7-MO-injected (2 ng/nl) embryos exhibited a small eye
phenotype (Fig. 3B,E) compared to control-MO (Fig. 3A,E) and
wild-type fish (Fig. 3E). We observed that the hearts of chd7-MO-
injected embryos were developmentally impaired and have signs of
severe pericardial edema compared to controls and wild-type fish
(Fig. 3 F). The atrial and ventricular chambers in these fish can be
distinguished (Fig 3. D), but these compartments were dysmorphic
and more tube-like (inset, Fig. 3 D) than the well-defined and
tightly looped chambers of control-MO injected fish and wild-type
fish (Fig. 3C). Injection of chd7 mRNA significantly rescued the
morpholino eye and heart phenotypes (Fig. 3E–F).
At 48 hpf, chd7-MO-injected (2 ng/nl) embryos also displayed a
very specific defect in otolith formation (n=6, 214 fish; Fig. 4B–
D). We observed that 63% of the morphants exhibited otoliths that
were asymmetric in size (135/214; p=0.006, ANOVA; Fig. 4
B,D), and 15% possessed only one otolith (32/214; p=0.008,
ANOVA; Fig. 4 C–D). The enlarged or single remaining otolith
was often shaped irregularly as opposed to the round and smooth
otoliths in control-MO (n=6, 249 fish; Fig. 4 C), wild-type
embryos or mRNA rescue embryos (Fig. 4-D). In addition, the
general size and morphology of the ear and the formation of
semicircular canals were affected in morphants with a single
otolith. Fish with defective otoliths also had a pronounced
curvature of the body axis, usually remained on their sides at
the bottom of their dish, and exhibited a circling swimming
behavior upon a touch (tail tap) or acoustic (dish tap) stimulation
(data not shown).
Chd7 plays critical roles in primary axis development and
vertebral mineralization
Loss of function of Chd7 led to a pronounced curvature of the
body axis in 25% of the morphants (n=12; p,0.001, ANOVA;
Fig. 5 A–C) compared to control-MO (n=12; Fig. 5 A,C) and
wild-type embryos (n=12; Fig. 5 C). This phenotype was
completed rescued by co-injection of chd7 mRNA (n=6; Fig. 5
C). Recently, CHD7 gene polymorphisms were associated with
susceptibility to idiopathic scoliosis in human populations [20]. We
therefore sought to examine vertebral phenotypes at various
developmental stages (Fig. 5 D–F). Chemical staining of the
vertebrae at later stages revealed that the spine of zebrafish
Figure 2. Chd7- MO injections and mRNA rescue experiments. Control-MO injected (E) chd7-MO+chd7-mRNA co-injected (F) zebrafish
showed no phenotypic defects at 48 hpf and were comparable to wild type zebrafish (A) at the same age. Embryos injected with 2 ng/nl chd7-MO
(B–C), or 2 ng/nl (D) chd7-SBMO showed several developmental defects.
doi:10.1371/journal.pone.0031650.g002
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but exhibited no scoliotic curves (n=6, 242 fish; Fig. 5 E,F).
Notably, chd7-MO-injected (2 ng/nl) fish had smaller, irregular
vertebral segments (n=6; Fig. 5 F), wider intervertebral disc space
(n=6; Fig. 5 F) and smaller neural and hemal spines (Arrows;
n=6; Fig. 5 F). The pedicles of the neural spines were in some
cases missing or fused. Mineralization can be assessed by the
intensity and localization of the alizarin red S stain [21] .We
observed a marked decrease in the alizarin red S staining of the
vertebral segments of chd7-MO-injected fish (n=6, 242 fish; Fig. 5
D–F) compared to control-MO ,suggesting a reduction in
vertebral mineralization in chd7 morphants . These data suggest
chd7 could play a critical role in vertebral development.
Chd7 is required for proper somite polarity and
segmental vascularization
Morpholino effects on protein abundance typically last for ,7
days [22] and surprisingly, we observed post-embryonic vertebral
defects in chd7-MO zebrafish. However, the skeletal malformation
observed in chd7-MO injected fish (in Fig. 5) resembles the
Figure 3. Knockdown of chd7 affects eye and heart development. (A–B) Representative images of eye phenotypes induced by injection of
chd7-MO in zebrafish embryos (B) compared with control embryos (A) at 72 hpf. Lateral view with anterior to right. Chd7 morphants had a reduced
ocular size. Chd7-MO-injected zebrafish exhibited cardiac anomalies such as dysmorphic heart and tube-like heart shape (D) compared with control
embryos (C). Insets in (C) and (D) represent an illustration of the heart phenotype in control or chd7 morphant embryos, respectively. (E–F) Bar
graphs illustrating the prevalence of eye (E) and heart (F) phenotypes in wild-type (white bar), chd7-MO (black bar), control-MO-injected embryos
(grey bar) and mRNA rescue (dark grey bar). ***,0.001, *,0.01. ***,0.001, *,0.01.
doi:10.1371/journal.pone.0031650.g003
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[23,24]. To determine whether the abnormality in segmentation
of the vertebral axis was due to developmental somite malforma-
tion, we analyzed the somite segmentation phenotype. To do so,
we examined expression of the segment-polarity gene, ephrin B2a
(efnb2a). In situ hybridization expression data for efnb2a revealed
defects in the delineation of somite borders. To verify this defect in
somite borders, a segment boundary marker, titin a (ttna), was used.
Specifically, zebrafish chd7 morphant embryos showed a loss of
distinct borders between individual somites at the 13 somite stage,
as exhibited by efnb2a expression (146 fish;p=0.008, t-test; Fig. 6
A–C) and ttna expression (112 fish; p=0.006, t-test; Fig. 6 D–F).
Stage matched control MO injected embryos exhibited distinct
expression of efnb2a within each somite (149 fish, Fig. 6 A–B), and
ttna expression marked clear boundaries between adjacent somites
(143 fish, Fig. 6 D–E). Sectioning of efnb2a stained embryos
revealed that this defect occurs throughout the somitic tissue in
chd7 morphants (inset, Fig. 6 A–B). Therefore, chd7 appears to be
important for proper segment boundary formation. These results
also suggest that the skeletal malformation observed later on
during development in chd7 morphants was likely caused by
defective somite segmentation.
Furthermore, since efnb2a is involved in arterial-venous
differentiation [25] and the development of intersegmental
vasculature is dependent on proper segmentation of the presomitic
mesoderm (PSM), we utilized a fli1: GFP transgenic zebrafish line
to test for defects in vascular development caused by Chd7
knockdown. With this resource, we observed aberrant vascular
organization. After 48 hours, chd7 MO injected embryos displayed
improper patterning of the intersegmental vasculature along the
long axis of the body (56 fish; p=0.001,t-test; Fig. 6 G–I). Since
these vessels form at the boundaries between somites [26], this
phenotype is likely due to a lack of intersomite specification in chd7
morphants, and is similar to defects observed in other mutants
defined by aberrant PSM segmentation [25].
Chd7 function is required for retinal organization
We next thought to further analyze the eye morphology of the
chd7 morphants. To permit a detailed assessment of the chd7-MO
small eye phenotype, histological analysis was performed on
embryos at 72 hpf (Fig. 7). Histology revealed that retinal
organization was severely disrupted in chd7-MO–injected embryos
(120 fish, Fig. 7 B). Specifically, the retinas lacked the chara-
cteristic laminated structure of both control-MO (142 fish, Fig. 7
A) and wild-type embryos at 72 hpf. Immunostaining further
confirmed disruption of retina formation. Retinal ganglion cells
appear to be reduced and disorganized in the chd7-MO–injected
embryos based on staining for the retinal ganglion marker Zn-8
(n=5; Fig. 7 C, D). Staining with 3A10, a neurofilament marker
was abnormal in that the normally recognizable stripe of
Figure 4. Knockdown of chd7 affects otolith development. (A) The otic vesicle of control-MO-injected fish contains two otoliths, by contrast,
larva treated with a morpholino against chd7 (B,C) had smaller otoliths (*) or only a single otolith (Arrow). Lateral views with anterior to the left. Ot,
otoliths (D) Bar graphs illustrating the prevalence of otolith phenotypes in wild-type (white bar), chd7-MO (black bar), control-MO-injected embryos
(grey bar) and mRNA rescue (dark grey bar). ***,0.001, *,0.01.
doi:10.1371/journal.pone.0031650.g004
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MO–injected embryos (n=8; Fig. 7 E, F). Similarly, cone photo-
receptor staining with Zpr-1 antibody was absent in chd7 morphants
(Figure S2). These findings suggest a novel role of Chd7 in retinal
organization and the development of photoreceptors.
Chd7 is essential for correct positioning of cranial motor
neurons and proper projection of facial and trigeminal
motor axons
Previous studies have demonstrated a role for Chd7 in neuronal
development [27,28,29] and patients with CHARGE syndrome
often display several neurological disorders. We found that chd7 is
expressed in the developing zebrafish hindbrain and loss of
function of chd7 leads to flattening of the head. To determine if
these molecules are required for proper neural development in this
area, we examined the cranial motor neurons of chd7-MO-injected
embryos using Isl1-GFP transgenic zebrafish embryos. These
embryos express GFP under the control of a motor neuron-specific
Isl1 promoter. Interestingly, we observed a disrupted organization
of the cranial motor neurons in the chd7-MO-injected embryos
(n=9; Fig. 8 B) when compared to control-MO-injected embryos
(n=9; Fig. 8 A). Chd7-MO-injected embryos demonstrated a
severe disorganization and clustering of both Va and Vp clusters of
the trigeminal (nV) neurons (Fig. 8 B). In addition, loss of Chd7
resulted in a reduction of facial (nVII) branchiomotor neuron
populations (n=9; Fig. 8 B). Furthermore, the vagal (nX) motor
neurons in chd7-MO-injected embryos exhibited aberrant medio-
lateral positioning and cell-to-cell spacing (n=9; Fig. 8 B). Chd7-
MO-injected embryos also exhibited extremely low levels of
staining of the peripherally extending axons from nV neurons
when compared to control-MO-injected embryos (n=9; Fig. 8 C,
D). Furthermore, chd7-MO injected embryos exhibited severe loss
of the facial sensory ganglion and the axonal extensions from nVII
neurons (n=9; Fig. 8 C, D).
Chd7 plays a key role in cranial neural crest development
CHARGE syndrome is thought to result from the abnormal
development of the neural crest. Recently, CHD7 and PBAF have
been shown to cooperate during embryonic development to
promote proper neural crest specification and cell migration [17].
We sought to examine the relationship between Chd7 and CNC
development in zebrafish using a Fli1-GFP transgenic zebrafish
line. We injected Fli1-GFP embryos with chd7-MO at the single
cell stage and then assayed for CNC defects between 34–36 hpf by
counting the number of CNC segments, which should approxi-
mate pharyngeal arch number, within each embryo. We observed
CNC defects in over 90% of chd7-MO-injected embryos (63 fish,
Fig. 9 D). About one third of these had a reduction in the number
of CNC segments, whereas the remaining animals showed more
severe phenotypes characterized by the gross disorganization or
absence of obvious CNC populations (Fig. 9 B, C). Disorganized
CNC segments tended to possess fewer cells and lacked sharp
borders between adjacent segments (Fig. 9 C). The phenotype of
control-MO-injected zebrafish embryos mimicked that of wild
type animals including well-defined segments and appropriate
segment numbers (71 fish, Fig. 9 A). These data lend support for
the function of Chd7 in proper CNC development and patterning.
Whether the defects reported here are due to aberrant CNC
Figure 5. Chd7 deficiency affects vertebral mineralization. Lateral view of control-MO (A) and chd7-MO-injected (B) fish at 3 dpf. Chd7
morphants exhibited a slight curvature of the long body axis (B). A significant percentage of the chd7-MO-injected (2 ng/nl) fish had deformed body
axis shape (C). Lateral views of chd7 morphants (lower panel) and control siblings (upper panel) at 8 dpf (D) and 14 dpf (E) showed a reduced bone
mineralization. Vertebrae with reduced or no hemal or neural spines were also observed in the chd7-MO-injected fish (F; black arrow). h, hemal spine;
n, neural spine. ***,0.001.
doi:10.1371/journal.pone.0031650.g005
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investigated.
Discussion
The present results show a novel and essential role of Chd7 in
retinal organization, axial patterning and bone development and
mineralization. Furthermore, knockdown of zebrafish chd7 results
in abnormalities similar to those described in CHARGE Synd-
rome, as we observed inner ear, heart, eye, cranial ganglia, neural
crest and skeletal defects in chd7 morphants. Collectively, our
findings demonstrate that Chd7 function is essential for proper
neural and cranial neural crest development. In addition, to our
knowledge, this is the first study to report the requirement of chd7
in retinal and vertebral development.
Chd7 has been implicated in spinal deformities [20] and scoliosis
isone ofthe minorclinicalfeaturesinsomeCHARGEpatients[11].
Here, loss of function of Chd7 resulted in the curvature of the body
axis, irregular vertebral segments and smaller neural and hemal
spines. The chd7 morphants did not exhibit any skeletal defects
reminiscent of a scoliotic adult phenotype, however, suggesting that
either scoliosis in CHARGE patients is secondary to the effects of
attenuated Chd7 levels, or due to primary effects that occur later in
development. Our findings also showed that zebrafish embryos
deficient in Chd7 mineralize vertebrae more slowly than control
siblings, indicating a critical role for Chd7 in promoting miner-
alization during normal development. Delays in vertebral miner-
alization may result from a general retardation in growth and
development; however, we did not detect any distinguishable
differences in length between the chd7 morphants and controls at all
developmental stages examined (Table S1). Interestingly, a similar
delay of mineralization in zebrafish has been reported after
knockdown of collagen XXVII [30]. Furthermore, in the absence of
BMP signaling, zebrafish bone mineralization was delayed [31].
Chd7 has been shown to regulate BMP signaling [27,32]. Thus, it is
possible that disruption of Chd7 affected the transcription of genes
that are crucial for bone mineralization. We also show that a loss of
somite border identity during somitogenesis, as exhibited by efnb2a
and ttna expression, is linked to a loss of organized segmental
vasculature following chd7 MO injection and skeletal defects. We
hypothesize that early defects in efnb2a expression lead to improper
segmental patterning later in development, affecting structures such
as segmental vasculature and bone mineralization. The link
between the process of somitogenesis and the defects in border
specification will require further investigation. For example, since
efnb2a expression persists after somite epithelialization, the irregular
Figure 6. Chd7 knockdown leads to somite boundary and segmental vasculature defects. Efnb2a expression in control morphant (A) and
chd7 morphant (B) zebrafish embryos at the 13-somite stage of development. Top is anterior. Insets in (A) and (B) represent coronal sections through
control or chd7 morphant embryos, respectively, at the 13 somite stage. Posterior views with dorsal towards the top. Expression of ttna, a segment
boundary marker reiterates the defects in segment boundary formation in chd7 morphants (E) compared to controls (D). Dorsal views with anterior
to the top. Segmental vasculature patterning is defective (arrowheads) in chd7 morphants (H) compared to control morphants (G) as visualized using
fli1: GFP transgenic zebrafish at 48 hpf. Sagittal views with anterior to the right. Graphs show percentages of animals exhibiting efnb2a expression
defects (C), ttna defects (F), or segmental vasculature patterning defects (I). The dark gray bar represents chd7 morphants and the light gray bar
represents control morphants. Scale bar: 200 mm. ***,0.001, **,0.01.
doi:10.1371/journal.pone.0031650.g006
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accumulation of upstream defects occurring early in the somitogen-
esis signaling pathway (i.e., indirect effects). Alternatively, it is also
possible that Chd7 modulates efnb2a expression in a manner that is
independent of the process of somite formation (i.e., direct effects).
CHARGE syndrome patients often have microphthalmia
[33,34,35] and here we found that loss of function of Chd7 in
zebrafish resulted in a small eye phenotype. The retinas in
zebrafish develop rapidly and begin differentiation by 36 hpf
[36,37]. The differentiating retinal neurons undergo terminal
Figure 7. Chd7 plays an essential role in retinal development. Retinal organization of control-MO embryos (A) and chd7 morphants (B)w a s
revealed by toludiene blue staining. Compared with the highly organized cells and laminated retinal structure in control-MO fish, chd7-MO retinal cells
are disorganized (A–B: Left panels). Retinal lamination defect, including rosette formation,is clearly visible in the chd7 morphants (examples of rosettes
are indicated by dotted lines and arrow heads). GL, ganglion cell layer; INL, inner nuclear layer; L, lens; ONL, outer nuclear layer; R, retina; RPE, retinal
pigment epithelium. Scale bar: 50 mm. Zn-8 immunoreactivity was performed to label (brown) retinal gangion cells in control-MO (C) and chd7-MO
embryos(D).Scalebar:30 mm.Theexpressionofretinalganglioncell-specific markerzn-8isgreatly reducedinchd7 morphants.Thephotoreceptorlayer
of control-MO (E) and chd7-MO-injected (F) embryos were stained with 3A10. Chd7 morphants lacked the photoreceptor layer. Scale bar: 5 mm.
doi:10.1371/journal.pone.0031650.g007
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[37,38,39]. A functional retina consists of a laminated neuronal
tissue with the ganglion cell layer on the inside, inner nuclear layer
in the middle, and the outer nuclear layer on the outside. In
between these layers are the synaptic layers: the inner and outer
plexiform layer [36,40]. Notably, the retinas in chd7 morphants fail
to laminate, which suggests a novel function for Chd7 in retinal
patterning. Furthermore, our findings are similar to disruptions in
retinal lamination as observed in the young zebrafish mutant that
carries a mutation in brg1, a gene that encodes for a subunit of the
Swi/Snf of ATP-dependent chromatin remodeling complexes
[37]. Moreover, retinal ganglion cells were reduced and the photo-
receptor layer were absent in the chd7-MO-injected embryos.
These data suggest that Chd7 is required for the development of
retinal cells. In Drosophila, the chd7 ortholog kismet is essential for
transcription of the pro-neural factor atonal (Atoh1) and regulation
of retinal photoreceptor cell development [41]. Drosophila ato
mutants produce no photoreceptors in the eye [42]. Chd7 has also
been recently shown to control the expression of sox9 [17].
Zebrafish sox9 mutants reveal that Sox9 is required for retinal
differentiation and it also helps with retinal organization and
regulates the number of photoreceptor cells [43]. Thus, it is likely
that that loss of function of Chd7 disrupts the gene network that is
crucial for retinal cellular development and organization.
Several ganglionic defects have been reported in CHARGE
patients, including defects in the facial and vestibulo-acoustic
ganglia [44,45]. Chd7 knockdown resulted in important pheno-
types relevant to cranial ganglia development, branchiomotor
development, and vagal motor neuron positioning. Anomaly in
facial nerves has also been demonstrated in CHARGE syndrome
[5]. Loss of function of Chd7 resulted in a severe loss of facial
nerves in the morphants. Altogether, these results suggest that
Chd7 and downstream targets are important for neuronal
development and proper axonal projections.
Neural crest cells are multipotent cell populations with the
ability to migrate, leading to the formation of several key
developmental structures including bones, cartilages, nerves, and
connective tissues [46]. CNC, specifically, migrate into the
pharyngeal arches where they play a role in the formation of
facial bone, muscle, and cartilage [47]. In addition, CNC migrate
into the optic vesicle and otic placode, where they play key roles in
the development of muscular and skeletal elements in the eye and
Figure 8. Chd7 is important for cranial ganglia development and proper projection of facial nerves. Dorsal view (rostal towards the top)
of confocal fluorescent composite images of hindbrain branchiomotor neurons in control-MO injected (A) and chd7-MO-injected (B) 48 hpf Isl1-GFP
transgenic embryos. (C, D) Confocal fluorescent composite images showing anti-3A10 antibody-stained axons of 48 hpf embryos. The broken lines
indicate the area of significant loss of VII nerves in chd7 morphants. nV, trigeminal motoneurons; Va, anterior trigeminal motoneurons; Vp, posterior
trigeminal motoneurons; nVII, facial motoneurons; nX, Vagal motoneurons; V, trigeminal nerve; VII, facial nerve. Scale bar: 50 mm.
doi:10.1371/journal.pone.0031650.g008
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defects in CHARGE patients can be traced to aberrant CNC
development, including coloboma of the eye, external ear
malformations, inner ear defects and a spectrum of facial defects
[6,50,51]. Our chd7 morphant zebrafish embryos displayed
obvious defects in CNC migration, based on observations of
pharyngeal arch development and number. We did not fully
characterize CNC activity in the optic nerve or otic placode of our
chd7 morphants, however, we did observe and quantify significant
defects in eye and otic vesicle development. CHD7 is essential for
the formation of multipotent migratory neural crest in humans and
Xenopus [17] and recently, CHD7 was found to play a role in
proper neurogenesis of the inner ear in mice [27]. Our results
support a role for Chd7 in proper CNC migration and
differentiation, and substantiate the use of chd7 morphant zebrafish
as an in vivo animal model for CHARGE Syndrome.
The chd7 –MO-injected embryos displayed a very specific defect
in otolith and semicircular canal formation and they also exhibited
a circling swimming behavior consistent with vestibular dysfunc-
tion. Such inner ear malformations are very similar to those
reported in CHARGE syndrome patients [52,53,54,55]. In
addition, CHARGE patients have been reported to have
vestibular problems and hyperactivity [56], and this may be due
to inner ear defects. CHD7 is necessary for proliferation of inner
ear neuroblasts and inner ear morphogenesis by the maintenance
of Fgf10, Otx2 and Ngn1 expression [27]. Fgf signaling and Otx
genes have also been shown to be important for inner ear
development in zebrafish [57,58,59,60]. Thus, our zebrafish
model for CHARGE syndrome can be useful to further explore
the mechanisms underlying inner ear anomalies in CHARGE
pathogenesis. For instance, it will be interesting to investigate
whether loss of function of chd7 in zebrafish results in a
downregulation of Fgf10 and Otx2 and whether overexpression
of one or more of these genes could rescue chd7 –MO phenotypes.
Heart defects have been reported to be associated with
CHARGE syndrome [2,3,5,61,62]. Here we report that the
hearts of chd7-MO-injected embryos are developmentally impaired
and have signs of severe pericardial edema. Heart anomalies
described in CHARGE syndrome patients include ventricular and
atrial septal defects and conotruncal defects [61,63]. In this study,
we did not fully characterize the observed heart defects in the chd7
morphants. The atrial and ventricular chambers in these fish can
be distinguished, but these compartments were dysmorphic and
more tube-like than the well-defined and tightly looped chambers
of wild-type fish. Future studies using chd7 zebrafish morphants
could help to identify components in the Chd7 regulatory network
that are essential for heart development and further our
understanding of one of the major anomalies reported in
CHARGE patients.
Figure 9. Knockdown of chd7 results in defects in CNC
development. Fli1-GFP transgenic embryos were used for MO
injections to determine whether Chd7 depletion had an effect on
CNC development. Embryos were injected at the 1 cell stage and
examined for effects at 34–36 hpf. (A) Control-MO injected zebrafish
embryos did not exhibit defects in CNC segment shape or number.
Alternatively, the majority of chd7-MO-injected embryos exhibited
aberrant CNC development including an improper number of CNC
segments (B), as well as severely disorganized (C) or missing CNC
populations. (D) Based on the t-test comparing means, there was a
significant difference in CNC defects between chd7-MO and control-
MO-injected zebrafish embryos. More than half of the chd7-MO-injected
fish had deformed or missing CNC segments and about one third
developed an improper number of segments. **=0.01; ***,0.001; e,
eye; mb, midbrain; pa1–5, pharyngeal arches 1–5.
doi:10.1371/journal.pone.0031650.g009
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We provide evidence that zebrafish highly express chd7 in the
retina, brain and somite boundaries. Loss of function of Chd7
resulted in several morphological defects similar to those observed
in patients with CHARGE syndrome. We then performed a
detailed analysis of uncharacterized defects of CHARGE syn-
drome and show that the presence of Chd7 is crucial for proper
neural, retinal and vertebral development in zebrafish. These data
provide new insights on the role of Chd7 and the mechanistic link
between defects in the Chd7 gene and the organs and systems
dysfunction associated with CHARGE syndrome. Furthermore,
on the basis of the overlap in clinical features between zebrafish
chd7 morphants and CHARGE syndrome, we suggest zebrafish
can be a valuable in vivo tool to further understand the
pathophysiological mechanisms underlying the abnormalities
associated with CHARGE syndrome.
Materials and Methods
Animals
Wild-type AB, Isl1-GFP WIK transgenic and Fli1-GFP
transgenic zebrafish (Danio rerio) embryos were raised at 28.5uC,
and collected and staged using standard methods [64]. Wild-type
AB stains fish and Fli1-GFP transgenic zebrafish were purchased
from the Zebrafish International Resource Center (ZIRC;
University of Oregon, Eugene, OR). Isl1-GFP WIK transgenic
line was kindly provided by Dr. Hitoshi Okamoto (RIKEN Brain
Science Institute, Wako, Japan) [65]. Embryos and larvae were
anaesthetized in 0.02% tricaine (MS-222; Sigma Chemical, St.
Louis, MO) in phosphate-buffered saline (PBS) prior to all
procedures.
Ethics Statement
All protocols were carried out in compliance with the guidelines
stipulated by the Canadian Council for Animal Care (CCAC), the
CHU Sainte-Justine Research Center, as well as the Institutional
Animal Care and Use Committee (IACUC) at Syracuse University
and at the University of Montreal. This study was approved by the
CHU Sainte-Justine Research Center ,University of Montreal (ZF-
09-60/Category B) and the Syracuse University (IACUC # 07-
010) ethics committees.
Design and synthesis of DIG-labeled RNA probes for
chd7, efnb2a and ttna
Total RNA was isolated from blastula stage zebrafish embryos
using the RNeasy Mini Kit (Quiagen, Valencia, CA). Reverse
transcription was performed to make cDNA using the QuantiTect
Reverse Transcription Kit (Quiagen, Valencia, CA). Chd7
fragments were amplified by PCR using 59-GCTATT-
GACCGCTTCTCTCG-39 and 59-TGCTCCTTTACGCAG-
GAGAT-39 primers (resulting in a 362 bp amplicon from about
halfway through the cDNA sequence) and cloned into the pGEM-
T Easy vector (Promega, Madison, WI) following the manufac-
turer’s protocol. Zebrafish efnb2a [66] and ttna [67] plasmids were
kind gifts from Dr. Steven Wilson and Dr. Andrew Oates
respectively. To synthesize the antisense probe, the previously
constructed plasmid was linearized using the restriction enzyme
SpeI (New England BioLabs, Inc., Ipswich, MA) for 2 hours at
37uC. Linearization was confirmed by gel electrophoresis using a
1% agarose gel. Linearized plasmid was incubated with T7 RNA
Polymerase (Roche Diagnostics, Indianapolis, IN) in the presence
of digoxigenin (DIG) label (Roche Diagnostics, Indianapolis, IN)
and RNase Inhibitor (Roche Diagnostics, Indianapolis, IN) for
2 hours at 37uC. To synthesize the sense strand, the restriction
enzyme ApaI (New England Biolabs, Inc., Ipswich, MA) and SP6
RNA Polymerase (Roche Diagnostics, Indianapolis, IN) were used.
Plasmid DNA was eliminated with DNase (Roche Diagnostics,
Indianapolis, IN) by incubation at 37uC for 20 minutes. DIG-
labeled RNA was precipitated in 0.2 M EDTA, 4 M LiCl, and
100% ethanol overnight at 220uC, and then resuspended in
DEPC water. Agarose gel electrophoresis was used to confirm the
presence of a purified probe and any unused probe was stored at
220uC.
Whole mount in situ hybridization analysis
Whole mount in situ hybridization was performed on staged
zebrafish embryos using both sense and antisense chd7, efnb2a and
ttna riboprobes. Methods for in situ hydridization analysis followed
[68,69]. Briefly, staged embryos were fixed overnight in 4%
paraformaldehyde, and then dehydrated in methanol. When ready
to use, embryos were rehydrated in phosphate buffered saline with
0.1% Tween-20 (PBSt). Embryos were permeabilized by protein-
ase K digestion and then hybridized with the riboprobes overnight
at 70uC. The next day, embryos were put through graded
solutions of 75%, 50%, and 25% prehybridized solution in 26
saline-sodium citrate (SSC) followed by a wash in 0.26 SSC for
30 minutes at 68uC. They were then placed in blocking solution
for several hours, and incubated in a-DIG antibody overnight.
Finally, embryos were washed again and incubated in staining
solution in the dark until sufficient staining appeared on the
embryos. Embryos were dehydrated in methanol to facilitate
clearing of background staining and then rehydrated in PBSt.
Embryos were stored in glycerol.
Embryos in glycerol were visualized using a Zeiss M2 Bio
Stereomicroscope, with motorized focus drive and X-Cite UV
light source with GFP filter. Images were captured using a Zeiss
Axiocam digital camera connected to an Antec PC and processed
with Adobe Photoshop 7.0.
Generation of zebrafish chd7 morpholino and mRNA
rescue experiments
To eliminate Chd7 function, two types of antisense morpholino
oligonucleotide were used to disrupt the translation of chd7
transcripts. The translation-blocking morpholino, 59-TGCAGC-
CAAGCTTAGAAGCAGGAC-39 and the splice blocking, 59-
TTATTTTCTGGCACTAACCATGTCC-39 were synthesized
by Gene Tools (Philomath, OR). The morpholino was injected
into single-cell stage zebrafish embryos at doses of 2 ng/embryo,
4 ng/embryo and 6 ng/embryo. To validate the function of the
chd7 splice blocking morpholino, RT-PCR was used to check for
improper splicing using the following primer set: forward- 59-
AGGTGGACTCCGAAGGAAAC-39, reverse- 59-CCGTCAT-
CACCACATTTGAG-39. Amplified cDNA was visualized using
gel electrophoresis.
To confirm the specificity of the chd7 morpholinos, a mismatch
morpholino (lower case) was used: TGgAcCCAAcCTTAcAAc-
CAGGAC (Gene Tools. OR). Furthermore, rescue experiments
were performed. Full-length wild type zebrafish chd7 gene was
subcloned into pcs2+ vector and capped mRNA was synthesized
using the Sp6 promoter and the mMessage mMachine Kit
(Ambion). Three hundred picograms of the synthetic mRNA was
then injected into embryos at the one-cell stage. Rescued embryos
were visualized and counted using the Olympus SZX12
stereoscope.
Injected and uninjected embryos were then incubated in
embryo media at 28.5uC for 24 h, after which they were assessed
for viability. Wild type, Isl1-GFP WIK and Fli1-GFP transgenic
zebrafish embryos injected with chd7 morpholino were assessed for
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uninjected embryos under an Olympus SZX12 stereoscope at 24,
48 and 72 hpf. Isl1-GFP transgenic zebrafish were stage matched
to 48 hpf and fixed in 4% paraformaldehyde for 4 h and then
analyzed for differences in branchiomotor neuron development
and migration from uninjected controls using a Zeiss AxioImager
Z1 compound microscope. Images were photographed using a
Zeiss LSM 510 confocal microscope at 488 nm under a 206
objective, and were compiled using Zeiss LSM Image Browser
software. Fli1-GPF zebrafish were staged to 34–36 hpf and
screened for CNC segmentation defects using an X-Cite UV light
source with GFP filter mounted to a Zeiss M2 Bio Stereomicro-
scope.
Immunohistological procedures
Zebrafish specimens were fixed in 4% paraformaldehyde and
were either used for whole-mount immunostaining or embedded
in paraffin. Transverse sections (1.5–3 mm) of paraffin-embedded
specimens were deparaffinized in xylene and were rehydrated in a
graded series of ethanol. Serial sections were collected from the
central retina.
For immunofluorescence microscopy, whole embryos and eye
sections were washed several times in PBS and permeabilized for
30 min in 4% Triton-X 100 containing 2% bovine serum
albumin (BSA) and 10% goat serum. Following permeabilization,
tissues and retinal sections were incubated in the primary
antibody 3A10 (Developmental Studies Hybridoma Bank;
1:500) for 48 h at 4uC on a shaker. Tissues and eye sections
were washed several times in PBS over a 24 h period, and then
incubated in the secondary antibody conjugated with Alexa Fluor
488 (Molecular Probes, Carlsbad, CA, 1:2000) for 4–6 h at room
temperature. Animals were washed in PBS several times, de-
yolked, cleared in 70% glycerol and mounted. Z-stack images
were photographed using a Zeiss LSM 510 confocal microscope
under a 206 objective, and were compiled using Zeiss LSM
Image Browser software.
For immunoperoxidase methods, slides were incubated with a
blocking serum (Vectastain; Vector Laboratories, Burlingame, CA)
for 45 minutes, after which they were blotted and then overlaid
with the primary antibodies Chd7 (Santa Cruz Biotechnology,
Santa Cruz, CA ; 1/600) and zn-8 (Developmental Studies
Hybridoma Bank; 1/200) for 18 hours at 4uC. The slides were
washed 3 times in PBS, pH 7.4, and incubated with secondary
antibodies (anti- mouse (1:1000) or anti- rabbit (1:1000),
Vectastain) for 1 hour at room temperature, followed by staining
according to the avidin-biotin-peroxidase complex method
(Vectastain ABC assay). Color was developed with 3,3-diamino-
benzidine (Dako Diagnostics Inc., Mississauga, ON, Canada)
containing hydrogen peroxide. Slides were counterstained with
Harris modified hematoxylin (Fisher Scientific, Ottawa, ON,
Canada). Eye sections were also stained with 1% Toluidine Blue.
Images were captured using a Leica DMR microscope mounted
with a Qimaging Retiga 1300 camera.
Skeletal staining
Juvenile zebrafish were fixed in 4% paraformaldehyde in PBS
for 48 hr at 4uC and dehydrated to 100% ethanol over 2 days.
Fish were then cleared in a 1% KOH solution containing
approximately 4.5 ml of 3% H2O2 per 100 ml 1% KOH for 2 h,
followed by 2 h in half this concentration (2.25 ml H2O2 per
100 ml 1% KOH). This latter step ensures a stepwise progression
from H2O2 to water, which helps reduce tissue expansion.
Zebrafish were then rinsed twice in distilled water, and transferred
to a 30% saturated sodium tetraborate solution (Borax; Acros
Organics) in water, overnight. Any remaining soft tissues were
digested in a solution containing 1.0% trypsin and 2.0% Borax in
water for 2–4 h. Digestion was deemed complete when the
primary axis of the axial skeleton became visible. The fish were
subsequently rinsed three times in distilled water to remove all
residual trypsin, prior to staining for 12 h or more in a solution of
75% ethanol and Alizarin red S. Vertebral mineralization was
assessed after Alizarin red S staining. Fish were examined using a
Leica M205FA stereomicroscope. Digital images were collected
with Leica DFC490 camera.
Calcein staining was performed as described [70]. Briefly, fish
were anesthetized in 0.6 mM MS-222 buffered to pH 7.0 and
immersed in 0.2% calcein in 10% Hank’s solution buffered to
pH 7.2 for 10 min followed by three 10 min washes in Hank’s
solution. Vertebral mineralization was assessed after calcein
staining using a Leica DMR microscope. Digital images were
collected with a Qimaging Retiga 1300 camera.
Sample number and statistical analysis
The sample number (n) refers to the batch number and each
batch number consisted of at least 40 fish. For each data set, we
provided the batch number followed by the total fish number
used. The sample number for wild-type fish consisted of 12
batches with a total of 510 fish used (n=12,510 fish); 12 batches
with a total of 436 fish for chd7 morphants (n=12,436 fish); 12
batches with a total of 498 fish for control-MO injected embryos
(n=12, 498 fish) and 6 batches with a total of 249 mRNA rescue
experiments (n=6, 249 fish). Immunohistochemistry were
performed on at least 6 batches for both control-MO and chd7-
MO fish. Statistical analyses were performed and data were
plotted in SigmaPlot 11.0 (Systat Software Inc., San Jose, CA,
USA). Significance was determined using paired Student’s t-tests,
one-way anovas and Fisher’s least significant difference tests for
normally distributed, equal variance data. Kruskal–Wallis anova
and Dunn’s method of comparison were used for non-normal
distributions.
Supporting Information
Figure S1 Chd7- MO injections are dosage dependent.
As the concentration of the chd7-MO injection increased, the
phenotypic defects became more severe. (A) Control-MO injected
zebrafish showed no phenotypic defects 48 hpf and were
comparable to wild type zebrafish at the same age. Embryos
injected with 2 ng/nl (B), 4 ng/nl (C), or 6 ng/nl (D) chd7-MO
showed increasing severity of developmental defects with increas-
ing MO concentration.
(TIF)
Figure S2 Chd7 plays an essential role in photoreceptor
development. The photoreceptor layer of control-MO (A) and
chd7-MO-injected (B) embryos were stained with Zpr-1. Chd7
morphants lacked the photoreceptor layer.
(TIF)
Table S1 Measurement of zebrafish size at different
ages.
(TIF)
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